Alzheimer’s disease is a growing epidemic with someone in the United States developing it every 66 seconds and is the nation’s sixth-leading cause of death. This is why Sigma Kappa is committed to putting an end to Alzheimer’s by creating a major funding stream to the national Alzheimer’s Association for research to find a cure.
Through Alzheimer’s disease and gerontology-related research grants from the Sigma Kappa Foundation, Sigma Kappa has become one of the nation’s leading private contributors to Alzheimer’s disease prevention, research and treatment efforts. Since 1989, the Sigma Kappa Foundation has granted more than $3 million in research grants including the lead gift of $1 million for the Women's Alzheimer’s Research Initiative. The gift funds clinical research focused on women, as well as studies led by female researchers who are working to advance Alzheimer's and dementia science.
We have raised